N-acetyl cysteine attenuates acute lung injury in the rat

Shock

Volumn 8, Issue 6, 1997, Pages 432-438

  Davreux, Christopher J ^a   Soric, Ivana ^a   Nathens, Avery B ^a   Watson, Ronald W G ^a   McGilvray, Ian D ^a   Suntres, Zacharias E ^b   Shek, Pang N ^b   Rotstein, Ori D ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b DEF AND CIV INST OF ENVIRON MED   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CD11 ANTIGEN; ENDOTOXIN; GLUTATHIONE; LIPOPOLYSACCHARIDE; PEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ANIMAL; ARTICLE; BLEEDING; BLOOD; CAPILLARY PERMEABILITY; CELL COUNT; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CYTOLOGY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; IMMUNOLOGY; INJURY; LEUKOCYTE ACTIVATION; LIPID PEROXIDATION; LIVER; LUNG; LUNG DISEASE; LUNG EDEMA; LUNG LAVAGE; MALE; METABOLISM; NEUTROPHIL; RAT; SPRAGUE DAWLEY RAT;

ACETYLCYSTEINE; ACUTE DISEASE; ANIMALS; ANTIGENS, CD11; ANTIOXIDANTS; BRONCHOALVEOLAR LAVAGE FLUID; CAPILLARY PERMEABILITY; CELL COUNT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXINS; GLUTATHIONE; HEMORRHAGE; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; LIVER; LUNG; LUNG DISEASES; MALE; NEUTROPHIL ACTIVATION; NEUTROPHILS; PEROXIDASE; PULMONARY EDEMA; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031301675     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/00024382-199712000-00007     Document Type: Article

References (47)

1. Fowler AA, Hamman RF, Good JT, et al: Adult respiratory distress syndrome: Risk with common predispositions. Ann Intern Med 99:293-298, 1983.
2. Demling RH: Current concepts on the adult respiratory distress syndrome. Circ Shock 30:297-309, 1990.
3. Dorinski PM, Gadek JE: Multiple organ failure. Clin Chest Med 11:581-591, 1990.
4. Repine JE: Scientific perspectives on adult respiratory distress syndrome. Lancet 339:466-472, 1992.
5. Giroir BP: Mediators of septic shock: New approaches for interrupting the endogenous inflammatory cascade. Crit Care Med 21:780-789, 1993.
6. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant out comes, and clinical trial coordination. Am J Respir Crit Care Med 149: 818-824, 1994.
7. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE: Acute respiratory distress in adults. Lancet 2:319-323, 1967.
8. Shoemaker WC, Appel PL, Bishop MH: Temporal patterns of blood volume, hemodynamics, and oxygen transport in pathogenesis and therapy of postoperative adult respiratory distress syndrome. New Horiz 1:522-536, 1993.
9. Rabinovici R, Bugelski PJ, Esser KM, Hillegass LM, Vemick J, Feuerstein G: ARDS-like lung injury produced by endotoxin in platelet-activat ing factor-primed rats. J Appl Physiol 74:1791-1802, 1993.
10. Kollef MH, Schuster DP: The acute respiratory distress syndrome. N Engl J Med 332:27-37, 1995.
11. Tomashefski JF Jr: Pulmonary pathology of the adult respiratory distress syndrome. Clin Chest Med 11:593-619, 1990.
12. Gonzalez PK, Zhuang J, Doctrow SR, et al: Role of oxidant stress in the adult respiratory distress syndrome: Evaluation of a novel antioxidant strategy in a porcine model of endotoxin-induced acute lung injury. Shock 6(Suppl 1):S23-S26, 1996.
13. Sznajder JI, Fraiman A, Hall JB, et al: Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure. Chest 96:606-612, 1989.
14. Richard C, Lemonnier F, Thibault M, Couturier M, Auzepy P: Vitamin E deficiency and lipid peroxidation during adult respiratory distress syn drome. Crit Care Med 18:4-9, 1990.
15. Inoue S, Nakao A, Kishimoto W, et al: Anti-neutrophil antibody attenuates the severity of acute lung injury in rats with experimental acute pancre atitis. Arch Surg 130:93-98, 1995.
16. Heflin AC, Brigham KL: Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. J Clin Invest 68:1253-1260, 1981.
17. McManus LM, Pinckard RN: Kinetics of acetyl glyceryl ether phospho- rylcholine (AGEPC)-induced acute lung alterations in the rabbit. Am J Pathol 121:55-68, 1985.
18. Shasby DM, VanBenthuysin KM, Tate RM, Shasby SS, McMurtry IF, Repine JE: Granulocytes mediate acute edematous lung injury in rabbits and isolated rabbit lung perfused with phorbol myristate acetate. Am Rev Resp Dis 125:443-447, 1982.
19. Till GO, Johnson KJ, Kunkel R, Ward PA: Intravascular activation of complement and acute lung injury. J Clin Invest 69:1126-1135, 1982.
20. Sjodin K, Nilsson E, Hallberg A, Tunek A: Metabolism of N-acetyl-L- cysteine: Some structural requirements for the deacetylation and conse quences for the oral bioavailability. Biochem Pharmacol 34:3981-3985, 1989.
21. Meister A, Anderson ME: Glutathione. Annu Rev Biochem 52:711-60, 1983.
22. Lauterburg BH, Corcoran GB, Mitchell JR: Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetamin ophen in rats in vivo. J Clin Invest 71:980-991, 1983.
23. Simon LM, Suttorp N: Lung cell oxidant injury: Decrease in oxidant mediated cytotoxicity by N-acetyl cysteine. Eur J Respir Dis 66(Suppl 139): 132-135, 1985.
24. 2 toxicity by N-acetyl cys teine. Eur Respir J 2:116-126, 1989.
25. Beehler CJ, Simchuk ML, Toth KM, et al: Blood sulfhydryl increases during hyeroxia: A marker of oxidant lung injury. J Appl Physiol 67: 1070-1075, 1989.
26. The National Research Council: Guide for the Care and Use of Laboratory Animals, Revised. Bethesda, MD: National Institutes of Health (NIH publication 85-23), 1985, pp 1-83.
27. Tietze F: Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues. Anal Biochem 27:502-522, 1969.
28. Jocelyn PC: Spectrophotometric assay of thiols. Methods Enzymol 143: 44-67, 1987.
29. Nathens AB, Rotstein OD, Dackiw APB, Marshall JC: Intestinal epithelial cells down-regulate macrophage TNF expression. A mechanism for imm une homeostasis in the gut associated lymphoid tissue. Surgery 118: 343-351, 1995.
30. Papanastasiou-Diamandi A, Christopoulos TK, Diamandis EP: Ultrasensitive thyrotropin immunoassay based on enzymatically amplified time-resolved fluorescence with a terbium chelate. Clin Chem 38:545-548, 1992.
31. Wang J-H, Redmond HP, Watson RWG, Bouchier-Hayes D: Role of lipopolysaccharide and tumour necrosis factor alpha in induction of he- patocyte necrosis. Am J Physiol 269:G297-G304, 1995.
32. Allen RC: Phagocytic leukocyte oxygenation activities and chemiluminescence: A kinetic approach to analysis. Methods Enzymol 133:449-492, 1986.
33. Asakawa T, Matsushita S: Thiobarbituric acid test for detecting lipid peroxides. Lipids 14:401-406, 1974.
34. Suntres ZE, Shek PN: Nitrofurantoin-induced pulmonary toxicity: In vivo evidence for oxidative stress-mediated mechanisms. Biochem Pharmacol 43:1127-1135, 1992.
35. Lowry OH, Rosebrough NJ, Farr NL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275, 1951.
36. Leff JA, Wilke CP, Hybertson BM, Shanley PF, Beehler CJ, Repine JE: Postinsult treatment with N-acetyl cysteine decreases IL-1 induced neutrophil influx and lung leak in rats. Am J Physiol 265:L501-L506, 1993.
37. Blackwell TS, Blackwell TR, Holden EP, Christman BW, Christman JW: In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol 157:1630-1637, 1996.
38. Kawai M, Nishikomori R, Jung E-Y, Tai G, Yamanaka C, Mayumi M, Heike T: Pyrrolidine dithiocarbamate inhibits intracellular adhesion mol ecule-1 biosynthesis induced by cytokines in human fibroblasts. J Immu nol 154:2333-2341, 1995.
39. Ziegler-Heitbrock HW, Stemsdorf T, Liese J, et al: Pyrrolidine dithiocar bamate inhibits NF-κB mobilization and TNF production in human mono cytes. J Immunol 151:6986-6993, 1993.
40. Bulger EM, Clinton CM, Garcia I, Helton WS, Roque RP, Maier RV: Enteral vitamin E supplementation inhibits the cytokine response to en dotoxin. Surgical Infection Society, vol. 6, p. 36, Pittsburgh, PA, May 1997 (abstract).
41. Schmalbach TK, Datta R, Kufe DW, Sherman ML: Transcriptional reg ulation of cytokine expression by diethyldithiocarbamate in human HL-60 promyelocytic leukemia cells. Biochem Pharmacol 44:365-371, 1992.
42. Jepsen S, Herlevsen P, Knudsen P, Bud MI, Klausen N-O: Antioxidant treatment with N-acetyl cysteine during adult respiratory distress syndrome: A prospective, randomized, placebo controlled study. Crit Care Med 20:918-923, 1992.
43. Suter PM, Domenighetti G, Schaller M-D, Laverriere MC, Ritz R, Perret C: N-acetylcysteine enhances recovery from acute lung injury in man. Chest 105:190-194, 1994.
44. Bernard GR: N-acetyl cysteine in experimental and clinical acute lung injury. Am J Med 91(Suppl 3C):54S-59S, 1991.
45. Sawyer MAJ, Mike JJ, Chavin K: Antioxidant therapy and survival in ARDS. Crit Care Med 17:S153, 1989 (abstract).
46. Metz C, Sibbald WJ: Anti-inflammatory therapy for acute lung injury: A review of animal and clinical studies. Chest 100:1110-1119, 1991.
47. Leff JA, Parsons PE, Day CE, et al: Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis. Lancet 341: 777-780, 1993.